| |
| |
|
| Insider
Information: |
Franco Richard A |
| Relationship: |
Director |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
554,802 |
|
|
Indirect Shares
|
4,500 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
559,302 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Salix Pharmaceuticals Ltd |
SLXP |
Director |
2012-04-05 |
68,468 |
2012-04-05 |
4,500 |
Premium* |
|
|
Point Therapeutics Inc |
POTP |
President & CEO, Direc... |
2011-05-12 |
246,334 |
|
0 |
Premium* |
|
|
Metropolitan Health Networks Inc |
MDF |
Former Director |
2012-12-21 |
0 |
|
0 |
Premium* |
|
|
Islet Sciences Inc |
ISLT |
Director |
2012-08-20 |
240,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| POTP |
Point Therapeutics Inc |
Chairman, President and CEOOff |
• • – |
2008-02-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
715,538 |
|
- |
|
| POTP |
Point Therapeutics Inc |
CEOOfficer |
• • – |
2009-01-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
447,820 |
|
- |
|
| MDF |
Metropolitan Health Netwo... |
Director |
– • – |
2010-04-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,000 |
|
- |
|
| ISLT |
Islet Sciences Inc |
Director |
– • – |
2012-08-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
240,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2003-11-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
15,650 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2003-11-12 |
4 |
D |
$18.04 |
$18,040 |
I/I |
(1,000) |
3,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2003-11-26 |
4 |
S |
$18.99 |
$18,990 |
D/D |
(1,000) |
11,650 |
|
- |
|
| POTP |
Point Therapeutics Inc |
President & CEO |
• • – |
2010-05-20 |
4 |
S |
$4.45 |
$4,450 |
D/D |
(1,000) |
100,835 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-07-01 |
4 |
D |
$39.83 |
$53,850 |
D/D |
(1,352) |
75,122 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-01-03 |
4 |
D |
$47.85 |
$68,856 |
D/D |
(1,439) |
73,683 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2004-02-27 |
4 |
S |
$26.65 |
$43,973 |
D/D |
(1,650) |
10,000 |
|
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2007-12-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,800 |
32,400 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
President & CEO |
• • – |
2010-05-24 |
4 |
S |
$4.18 |
$8,360 |
D/D |
(2,000) |
102,835 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-11-22 |
4 |
S |
$43.80 |
$109,500 |
D/D |
(2,500) |
34,334 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2008-07-01 |
4 |
D |
$7.03 |
$20,120 |
D/D |
(2,862) |
42,038 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2003-11-12 |
4 |
D |
$18.74 |
$56,220 |
D/D |
(3,000) |
12,650 |
|
- |
|
| POTP |
Point Therapeutics Inc |
President & CEO |
• • – |
2010-05-19 |
4 |
S |
$3.85 |
$11,920 |
D/D |
(3,096) |
99,835 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2008-12-22 |
4 |
S |
$8.51 |
$29,775 |
D/D |
(3,500) |
51,214 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
President & CEO |
• • – |
2011-04-26 |
4 |
B |
$2.78 |
$9,730 |
D/D |
3,500 |
166,334 |
2.81 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-07-01 |
4 |
D |
$39.03 |
$147,143 |
D/D |
(3,770) |
45,474 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2009-07-01 |
4 |
D |
$9.87 |
$38,789 |
D/D |
(3,930) |
47,284 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2012-04-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,160 |
68,468 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2010-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
4,360 |
49,834 |
0 |
- |
|
| SLXP |
Salix Pharmaceuticals Ltd |
Director |
– • – |
2011-04-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,640 |
76,474 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
President & CEO |
• • – |
2010-08-31 |
4 |
B |
$2.29 |
$11,450 |
D/D |
5,000 |
107,835 |
2.81 |
- |
|
52 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
